Specifically, while APOE4 carriers exhibit lower glucose tolerance even before developing the pathological signs of AD, epigenomic modifications of the APOE4 gene, and its effect on glucose metabolism can also serve as a basis for identifying future preventive strategies. Here, APOE is linked to Alzheimer disease.